DD vs KURA · P/E 127, rev $3.50B vs rev $20.9M
Dupont De Nemours Inc (DD) versus Kura Oncology Inc (KURA) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Kura Oncology Inc (KURA) is a biotechnology company listed on NASDAQ.
Latest reported DD revenue for 2026-06-30 was $3.50B. Net income was $304.0M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported KURA revenue for 2026-06-30 was $20.9M. Net income was -$68.3M. Revenue was up 14.3% from 2026-03-31 to 2026-06-30. KURA currently screens at market cap $861.1M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. KURA currently screens at market cap $861.1M.
Not investment advice. Open the DD and KURA stock pages for the full models.
Not investment advice.